GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (STU:0JS) » Definitions » Cyclically Adjusted Price-to-FCF

MedMen Enterprises (STU:0JS) Cyclically Adjusted Price-to-FCF : (As of Sep. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


MedMen Enterprises Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for MedMen Enterprises's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Cyclically Adjusted Price-to-FCF Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MedMen Enterprises's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Cyclically Adjusted Price-to-FCF falls into.



MedMen Enterprises Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

MedMen Enterprises's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, MedMen Enterprises's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.009/127.3478*127.3478
=-0.009

Current CPI (Mar. 2023) = 127.3478.

MedMen Enterprises Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201304 -0.067 98.107 -0.087
201307 -0.112 98.557 -0.145
201310 -0.024 98.536 -0.031
201401 0.000 98.692 0.000
201404 -0.240 100.023 -0.306
201407 -0.039 100.520 -0.049
201410 0.027 100.176 0.034
201501 -0.044 98.604 -0.057
201504 -0.051 99.824 -0.065
201507 -0.039 100.691 -0.049
201510 -0.029 100.346 -0.037
201601 -0.032 99.957 -0.041
201604 -0.058 100.947 -0.073
201607 -0.031 101.524 -0.039
201610 -0.029 101.988 -0.036
201701 -0.039 102.456 -0.048
201704 -0.051 103.167 -0.063
201707 -0.043 103.278 -0.053
201710 0.000 104.070 0.000
201801 0.002 104.578 0.002
201804 -0.003 105.708 -0.004
201809 -1.313 106.507 -1.570
201812 -1.277 105.998 -1.534
201903 -0.640 107.251 -0.760
201906 -0.493 108.070 -0.581
201909 -0.293 108.329 -0.344
201912 -0.239 108.420 -0.281
202003 -0.057 108.902 -0.067
202006 -0.068 108.767 -0.080
202009 -0.037 109.815 -0.043
202012 -0.025 109.897 -0.029
202103 -0.022 111.754 -0.025
202106 -0.019 114.631 -0.021
202109 -0.021 115.734 -0.023
202112 -0.023 117.630 -0.025
202203 -0.010 121.301 -0.010
202206 -0.003 125.017 -0.003
202209 -0.007 125.227 -0.007
202212 -0.003 125.222 -0.003
202303 -0.009 127.348 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MedMen Enterprises  (STU:0JS) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


MedMen Enterprises Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises Business Description

Traded in Other Exchanges
N/A
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises Headlines

No Headlines